• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童接种减毒活日本脑炎疫苗后是否需要加强免疫?

Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?

机构信息

Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

J Trop Pediatr. 2013 Oct;59(5):423-5. doi: 10.1093/tropej/fmt043. Epub 2013 Jun 13.

DOI:10.1093/tropej/fmt043
PMID:23764540
Abstract

Japanese encephalitis virus is a common cause of encephalitis in Asian children; therefore, maintenance of immunity against Japanese encephalitis virus is essential. Although many countries recommend booster vaccination, some trials have concluded that administration of one or two vaccinations is sufficient. The current study was conducted to evaluate immunogenicity and safety after a booster vaccination with live attenuated vaccine. For 68 study subjects, measurement of antibody titer was performed before and at 4-6 weeks after administration of a booster dose. Adverse reactions occurring at the injection site and systemic adverse reactions were documented. The percentages of subjects with seroprotective neutralizing antibody titers was 100% before and after booster vaccination, and the geometric mean titer increased after booster vaccination. Thus, we predict that immunity will be maintained for a long time by an amnestic response. Low percentages of adverse reactions indicated the safety of the immunizations.

摘要

日本脑炎病毒是亚洲儿童脑炎的常见病因;因此,保持对日本脑炎病毒的免疫力至关重要。尽管许多国家建议加强疫苗接种,但一些试验得出的结论是,接种一剂或两剂疫苗就足够了。本研究旨在评估用减毒活疫苗进行加强免疫后的免疫原性和安全性。对 68 名研究对象在接种加强剂量前后 4-6 周进行抗体滴度测量。记录注射部位和全身不良反应的发生情况。接种加强针前后,具有血清保护性中和抗体滴度的受试者百分比均为 100%,且加强针接种后几何平均滴度增加。因此,我们预测通过记忆应答将长期维持免疫力。不良反应的低发生率表明免疫接种的安全性。

相似文献

1
Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?儿童接种减毒活日本脑炎疫苗后是否需要加强免疫?
J Trop Pediatr. 2013 Oct;59(5):423-5. doi: 10.1093/tropej/fmt043. Epub 2013 Jun 13.
2
Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.在泰国儿童中,用SA14-14-2疫苗进行初次接种后,以日本脑炎嵌合病毒疫苗作为加强剂量的免疫原性。
Vaccine. 2016 Oct 17;34(44):5279-5283. doi: 10.1016/j.vaccine.2016.09.005. Epub 2016 Sep 12.
3
Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.韩国健康儿童初次免疫1年后接种一剂减毒活日本脑炎嵌合疫苗加强针的免疫原性和安全性
Pediatr Infect Dis J. 2016 Feb;35(2):e60-4. doi: 10.1097/INF.0000000000000967.
4
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.嵌合型减毒活乙型脑炎疫苗(ChimeriVax-JE):安全性和免疫原性的2期临床试验、疫苗剂量和接种程序的效果以及对灭活乙型脑炎抗原攻击的记忆反应
J Infect Dis. 2003 Oct 15;188(8):1213-30. doi: 10.1086/378356. Epub 2003 Oct 3.
5
Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.在泰国为9至15个月大的儿童接种减毒活SA14-14-2日本脑炎疫苗。
J Med Assoc Thai. 2011 Aug;94 Suppl 3:S195-203.
6
Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.初免一剂vero 细胞培养灭活流行性乙型脑炎疫苗(JE-VC)后的长期免疫原性,以及既往接种过鼠脑源灭活流行性乙型脑炎疫苗儿童再次接种JE-VC 疫苗的安全性和免疫原性。
Vaccine. 2018 Mar 7;36(11):1398-1404. doi: 10.1016/j.vaccine.2018.01.075.
7
Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.初免和加强免疫接种乙型脑炎疫苗的交叉保护作用:一项为期两年的随访研究。
Vaccine. 2013 Dec 17;32(1):119-23. doi: 10.1016/j.vaccine.2013.10.055. Epub 2013 Oct 28.
8
Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.曾接种过灭活日本脑炎疫苗的斯里兰卡儿童中,减毒活疫苗日本脑炎SA 14-14-2的免疫原性。
Vaccine. 2016 Nov 21;34(48):5923-5928. doi: 10.1016/j.vaccine.2016.10.028. Epub 2016 Oct 20.
9
Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.减毒活嵌合日本脑炎疫苗作为SA14-14-2减毒活疫苗初次接种后的加强剂量的免疫原性:泰国儿童的IV期研究。
Pediatr Infect Dis J. 2017 Feb;36(2):e45-e47. doi: 10.1097/INF.0000000000001395.
10
Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.使用日本脑炎灭活疫苗加强免疫六年后抗体的持续性。
Vaccine. 2015 Jul 9;33(30):3600-4. doi: 10.1016/j.vaccine.2015.05.037. Epub 2015 May 30.

引用本文的文献

1
Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.使用减毒活日本脑炎疫苗 SA 14-14-2 于儿童:安全性和耐受性研究的回顾。
Hum Vaccin Immunother. 2017 Oct 3;13(10):2222-2231. doi: 10.1080/21645515.2017.1356496. Epub 2017 Aug 25.
2
Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic review.现有日本脑炎疫苗的免疫原性和安全性:一项系统评价。
Hum Vaccin Immunother. 2014;10(12):3579-93. doi: 10.4161/21645515.2014.980197.